CIK 0001689375 · Accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entrada Therapeutics, Inc.
Sign in to watch- Ticker
- TRDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813983399
- Phone
- 857-305-1825
- Business address
- ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
- Former names
- CycloPorters, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,200,939
- in 8 filings
Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-17 | Doshi Dipal CEO | Sale 10b5-1 | −1,200 | $15.11 | $18K | 337,375 |
| 2024-05-16 | Sethuraman Natarajan Chief Scientific Officer | Sale 10b5-1 | −1,000 | $15.00 | $15K | 208,032 |
| 2024-05-16 | Doshi Dipal CEO | Sale 10b5-1 | −1,800 | $15.00 | $27K | 338,575 |
| 2024-05-14 | KIM PETER S Director | Purchase | +25,000 | $14.59 | $365K | 117,412 |
| 2024-05-14 | KIM PETER S Director | Purchase | +25,000 | $14.59 | $365K | 92,412 |
| 2024-05-13 | KIM PETER S Director | Purchase | +25,000 | $14.68 | $367K | 92,412 |
| 2024-05-09 | KIM PETER S Director | Purchase | +2,200 | $14.25 | $31K | 67,412 |
| 2024-05-08 | KIM PETER S Director | Purchase | +2,276 | $14.04 | $32K | 65,212 |
| 2024-04-08 | KIM PETER S Director | Purchase | +2,600 | $13.57 | $35K | 62,936 |
| 2024-03-28 | KIM PETER S Director | Purchase | +1,512 | $13.75 | $21K | 60,336 |
| 2024-03-26 | KIM PETER S Director | Purchase | +2,750 | $13.64 | $38K | 58,824 |
| 2024-03-25 | KIM PETER S Director | Purchase | +3,180 | $13.36 | $42K | 56,074 |
| 2024-03-22 | KIM PETER S Director | Purchase | +3,118 | $13.76 | $43K | 52,894 |
| 2024-03-21 | KIM PETER S Director | Purchase | +704 | $13.24 | $9K | 49,776 |
| 2024-03-20 | KIM PETER S Director | Purchase | +1,128 | $12.66 | $14K | 49,072 |
| 2024-03-19 | KIM PETER S Director | Purchase | +900 | $12.66 | $11K | 47,944 |
| 2024-03-15 | WENTWORTH KORY JAMES Chief Financial Officer | Option exercise | +9,000 | $2.10 | $19K | 83,170 |
| 2024-03-15 | WENTWORTH KORY JAMES Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −9,000 | 43,157 | ||
| 2024-03-06 | WENTWORTH KORY JAMES Chief Financial Officer | Sale 10b5-1 | −4,086 | $12.31 | $50K | 74,170 |
| 2024-03-06 | Dowden Nathan J President & COO | Sale 10b5-1 | −1,826 | $12.32 | $22K | 137,204 |
Page 11 of 12 · 230 trades